MG-63 osteoblast-like cells enhance the osteoprotegerin expression of PC-3 prostate cancer cells

Anticancer Res. 2009 Oct;29(10):4013-8.

Abstract

Background: Osteoprotegerin (OPG) expression participates in the pathophysiology of osteoblastic metastasis in prostate cancer.

Materials and methods: We investigated whether the expression of OPG of PC-3 prostate cancer cells grown in 3-D collagen gels is stimulated by co-culture with MG-63 osteoblast-like cells. The expression of Runx2 (Cbfa1) and OPG were assessed by reverse transcription-polymerase chain reaction and Western blot analysis.

Results: OPG and Runx2 were expressed in both PC-3 and MG-63 cells. OPG expression was remarkably enhanced in PC-3 cells grown in co-culture with MG-63 cells in a time-dependent manner. Runx2 expression of PC-3 cells was not altered by their co-culture with MG-63 cells. OPG expression of PC-3 cells was altered neither by insulin-like growth factor I (IGF-1), transforming growth factor beta1 (TGFbeta1), interleukin 6 (IL-6) nor by dexamethasone and zoledronic acid exogenously added to PC-3 cells.

Conclusion: The enhancement of the OPG expression in PC-3 cells by MG-63 cells is not mediated by IGF-1, IL-6 and TGFbeta1.

MeSH terms

  • Bone Neoplasms / pathology
  • Bone Neoplasms / secondary
  • Cell Communication / physiology*
  • Coculture Techniques
  • Core Binding Factor Alpha 1 Subunit / biosynthesis
  • Humans
  • Insulin-Like Growth Factor I / pharmacology
  • Interleukin-6 / pharmacology
  • Male
  • Osteoblasts / metabolism
  • Osteoblasts / pathology*
  • Osteoprotegerin / biosynthesis*
  • Osteosarcoma / metabolism
  • Osteosarcoma / pathology
  • Prostatic Neoplasms / metabolism*
  • Prostatic Neoplasms / pathology*
  • Transforming Growth Factor beta1 / pharmacology

Substances

  • Core Binding Factor Alpha 1 Subunit
  • Interleukin-6
  • Osteoprotegerin
  • RUNX2 protein, human
  • TNFRSF11B protein, human
  • Transforming Growth Factor beta1
  • Insulin-Like Growth Factor I